Market Place
Sourcing Support
USFDA’s list of drugs that need generic alternatives
In
its continuous endeavor to bolster the competitiveness of the generics
market, the US Food
Mylan board survives shareholder meet; Evaluate lowers drug sales growth forecast
This week, Phispers brings you news on the oversubscription of EU’s online pharmacy Zur Rose,
PharmaCompass finds 500 drugs with ‘no patents and no competition’ in the FDA Orange Book
In April last year, PharmaCompass
had shared a list of over 300
different dosage forms of drugs whic
Trump’s comments on drug prices sink pharma stocks; Teva lowers guidance by $ 1 billion
The New
Year began with the JP Morgan Healthcare Conference— the drug industry’s annual
Price gouging by Aspen in Italy; explosion at BASF; India acts on illegal Metformin exports
This week, Phispers gets you news on illegal exports of Metformin in India, Hillary Clinton’s
Drugs with no patents and no competition – here’s our list of new ‘price-gouging’ targets
Drug price increases have emerged as a core strategy for generic pharmaceutical companies in the rec
